Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562.
127828-22-2
139115-91-6
165963-71-3
108466-89-3
462100-06-7
1076199-21-7
10135-38-3 | 3,3,5,5-Tetramethyl-1-pyrroline n-oxide | AA000488 | MFCD00010542
1015242-58-6 | 4-Methyl-2,3-dihydro-1,4-benzoxazine-6-boronic acid | AA0004MK | MFCD20441848
1015846-84-0 | 3-Pyridinemethanamine, α-(3,4-dimethylphenyl)- | AA0004TS | MFCD09902268
1017027-77-8 | 2-Cyclopropylbenzo[d]oxazol-5-amine | AA00055Y | MFCD09947485
101803-03-6 | Guanosine, 2'-deoxy-N-ethyl- | AA0005JF | MFCD01631004
101930-07-8 | (R)-(+)-1-Benzyl-3-pyrrolidinol | AA0005WE | MFCD00075484
102-32-9 | 3,4-Dihydroxyphenylacetic acid | AA000664 | MFCD00004338
102040-03-9 | Tubeimoside i | AA0006DF | MFCD03427680
102153-71-9 | Naphthalene, 2-iodo-3-nitro- | AA0006PB | MFCD06656539
1022931-73-2 | tert-Butyl 3-(trifluoromethyl)-1h,4h,5h,6h,7h-pyrazolo[4,3-c]pyridine-5-carboxylate | AA00071Z | MFCD11044975